title: Studies of immunosuppression with quadruple regimen treatment (cyclosporine, mizoribine, prednisolone, and antilymphocyte globulin) in cadaveric and living-related donor renal allotransplantation.
authors.affiliation: Department of Surgery, Kitasato University, School of Medicine, Kanagawa, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Sato
authors.forename: K
authors.initials: K
authors.lastname: Matsuzawa
authors.forename: F
authors.initials: F
authors.lastname: Tadokoro
authors.forename: A
authors.initials: A
authors.lastname: Kakita
authors.forename: M
authors.initials: M
authors.lastname: Okubo
authors.forename: K
authors.initials: K
authors.lastname: Kumano
authors.forename: K
authors.initials: K
authors.lastname: Mashimo
authors.forename: T
authors.initials: T
authors.lastname: Endo
authors.forename: K
authors.initials: K
authors.lastname: Watanabe
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D006085:Graft Survival / Q000187:drug effects; D006680:HLA Antigens / Q000235:genetics; D006239:Haplotypes; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects / Q000379:methods*; D011239:Prednisolone / Q000008:administration & dosage; D012263:Ribonucleosides / Q000008:administration & dosage
chemical_list: D000961:Antilymphocyte Serum; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D011239:Prednisolone